Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SR147778 in Obese Patients
NCT00239174Phase 2Completed
- Sponsor
- Sanofi
- Start
- Nov 2004
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of surinabant in obesity, sponsored by Sanofi. Started Nov 2004; status: completed.
02
Drugs
surinabant
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00239174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239174.